SodaMelt Testing And Quality

Eight quality claims, sorted by whether a reader can settle them. The last two are the ones that would change a purchase decision most.

Read the third column and the shape of this label comes into focus. Everything about the bottle as an object is checkable. Everything about the proportions inside it is closed, and no mark on the pack opens it.

Good Manufacturing PracticeA process standard governing how a facility documents, controls and records what it makes. It says the production line is run to a written system. It reports nothing about this batch.

FDA-registered facilityThe factory is on the agency's register of food facilities. Registration is a filing obligation, not an inspection outcome, and the agency does not approve dietary supplements at all.

Foreign and domestic ingredientsThe same sentence the label prints in words: manufactured in the USA with globally sourced ingredients. A sourcing statement rather than a quality grade.

60-day money-back guaranteeThe only mark of the four this desk can act on. It is a purchase policy with a published claim process, and it is checkable because you can use it.

Three of the four are statements about a building and a process. The fourth is a commercial promise. Between them they cover how the capsule was made and what happens if you want your money back, which is useful, and they cover nothing about what the capsule does.

That is not a criticism of this pack specifically. It is what supplement seals are: almost all of them describe manufacturing or policy. Reading them as evidence of efficacy is the mistake, and it is an easy one when four of them sit in a row.

This is the most misread mark in the category, so it is worth slowing down on.

Facilities that manufacture, process, pack or hold food for consumption in the United States are required to register with the agency. Dietary supplements fall inside that definition. Registration is therefore a legal obligation a factory meets, in the same way a company registers with a tax authority.

It follows that registration is not a review of the product, not an inspection result, and not an endorsement. The agency does not approve dietary supplements before they go on sale at all, which is the reason every page on this website carries the disclaimer at the foot of it.

Every mark above describes the process. The thing a buyer most wants tested is the formula, and on this label that runs into a wall of the label's own making.

Eleven entries share one 250 mg figure. A laboratory could assay the blend total and report it as accurate to the milligram, and a reader would still be unable to tell whether psyllium husk is most of it or a trace. The panel marks the blend's %DV as a Daily Value not established, which is correct and which also means there is no reference figure to measure it against.

Set that beside the published research and the scale of the gap is easy to state. van der Schoot's fibre meta-analysis found fibre helped chronic constipation only above 10 g a day. the Martoni DDS-1 trial ran Lactobacillus acidophilus DDS-1 at ten billion CFU a day. The whole blend is 250 mg, which is a quarter of a gram, before the other nine entries take their share.

Six rows here; the full twelve are on the ingredients page with a source against each. The point of printing them is not to argue the capsule is worthless. It is that no seal on the pack, and no certificate the manufacturer could produce, would close the distance between those two columns.

Testing and quality is usually read as a question about contamination. On a panel carrying four anthraquinone botanicals it is also a question about what is deliberately in the bottle, and that record is public.

van Gorkom's review of anthranoid laxatives is the standing review of the class and it is explicit that long-term use cannot be recommended. Nascimbeni's aberrant crypt foci study documents the pigment change in the bowel lining that follows sustained anthranoid use. Gurley's in vivo cytochrome P450 study measured goldenseal altering the liver enzymes that clear a large share of prescription medicines.

None of that is a contamination finding and none of it is a manufacturing defect. It is the ordinary pharmacology of the plants on the panel, it is why the bottle carries the caution it carries, and it is treated at length on the side effects page rather than repeated here.

• No laboratory report for lot SOD-26/SO-2224 has been seen by this desk. The lot and the certificate reference index a batch; neither is a result.
• The GMP and FDA-registration marks have been read as what they claim. Neither has been independently confirmed by anyone writing this page.
• The sourcing statement is the label's own, repeated by a seal. There is no audit behind it that this desk has read.
• The proportions inside the 250 mg blend are set by the manufacturer and are outside anybody else's reach.
• No CFU count is given for the probiotic strain, so its viability at the point of sale cannot be estimated from the label.

Publishing that list is the point of the page. A quality section that only lists what can be confirmed reads as reassurance; one that also lists what cannot lets a reader decide how much the confirmable half is worth.

The 60-day guarantee is the practical answer to most of it. It moves the risk of being wrong about this capsule onto the seller for two months, and the guarantee page sets out exactly how far that goes.